(1)
Tamrakar, R.; Tamrakar, D. Virologic Response Following a Switch to Dolutegravir-Based Regimen in People Living With HIV/AIDS at a Tertiary Care Center in Nepal. Kathmandu Univ. Med. J. 2022, 20, 438-442.